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Abstract
Introduction: Staphylococcus lugdunensis is an unusually virulent coagulase-negative
staphylococcus that has rarely been implicated in central nervous system infections.
Case presentation: Two children hospitalized in the Neurosurgery Unit developed ventriculitis
caused by methicillin-resistant Staphylococcus lugdunensis following placement of external
ventriculostomy drains. The causative organisms were identified by molecular studies. The patients
recovered without significant sequelae after high doses of intrathecal vancomycin.
Conclusion: Distinguishing Staphylococcus lugdunensis from other coagulase-negative
staphylococcus species is crucial because it carries a substantial risk for severe central nervous
system infections displayed by patients with implanted cerebrospinal fluid devices. Clinicians should
not underestimate the importance of the isolation of this species from cerebrospinal fluid
specimens.
Introduction
First described by Freney et al. in 1988 [1], Staphylococcus
lugdunensis is an unusually virulent coagulase-negative
staphylococcus (CoNS) known primarily as a cause of
endocarditis, especially in immunocompromised patients
[2]. It has also been associated with septic arthritis, osteo-
myelitis, peritonitis, brain abscesses, and infections of the
skin and soft tissues, urinary tract, and prosthetic medical
devices [3]. Its remarkable virulence has been attributed to
the production of extracellular slime, which facilitates col-
onization and interferes with phagocytosis-associated
activities of neutrophils [4]. Some strains also produce a
synergistic hemolysin that resembles the δ-hemolysin of
S. aureus, consisting of three very similar 43-residue pep-
tides closely related to the gonococcal-growth-inhibitor
bacteriocin secreted by S. haemolyticus. Nucleic acid
sequences related to the accessory gene regulator (the
major determinant of virulence in S. aureus) have also
been demonstrated in S. lugdunensis [5].
A MEDLINE search conducted with the keywords "S. lug-
dunensis" AND "cerebrospinal fluid (CSF)-shunt infec-
tion" OR "central nervous system (CNS) infection"
yielded only four cases, which are summarized in Table 1.
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neal shunt (VPS) infections [6,7], and case #4 was a S. lug-
dunensis meningitis unrelated to implanted CSF drainage
devices [8]. The other two cases of S. lugdunensis infections
reported in Table 1 were recently diagnosed in the Pediat-
ric Neurosurgery Unit of our Medical Center.
This report analyzes the management of these patients in
light of the few previously reported cases of S. lugdunensis
CNS infections and summarizes the molecular character-




A 7-year-old boy was hospitalized in the Pediatric Neuro-
surgery Unit for headache, vomiting, and right ocular dys-
metria. Magnetic resonance imaging (MRI) revealed
obstructive hydrocephalus caused by a posterior fossa
tumor. The child was taken to the operating room for
placement of an external ventriculostomy drain (EVD).
CSF cultures yielded no growth. There was no improve-
ment and, on the 10th day of hospitalization, he had a sec-
ond operation for partial removal of the tumor (a
medulloblastoma). A new EVD was inserted; cultures of
the original EVD and CSF yielded no growth. Seven days
later, the child developed severe headache, fever
(39.5°C), vomiting, lethargy, and signs of EVD malfunc-
tion. Shunt puncture yielded cloudy CSF containing 900
leukocytes/mm3 (80% polymorphonuclear cells); 100 mg
protein/dl); and 21 mg glucose/dl (blood glucose: 87 mg/
dl). Cytocentrifuge Gram staining revealed Gram-positive
cocci that were later identified by biochemical and molec-
ular methods as Staphylococcus lugdunensis.
Meanwhile, a presumptive diagnosis of ventriculitis was
made [9], a new EVD was inserted, and intrathecal (IT)
vancomycin (40 mg/day) was started. Cultures of the CSF
and the ventricular tip of the second EVD grew methicil-
lin-resistant S. lugdunensis. Three blood cultures yielded
no growth. Swabs of both inguinal folds and the surgical
incision were cultured, but none yielded S. lugdunensis.
Defervescence occurred after 2 days of IT vancomycin.
After 14 days of vancomycin, the composition of the CSF
was normal, and cultures of CSF and EVD were negative.
The boy was discharged after 62 days of hospitalization,






















































































EVD 19 days Fever, seizures,
impaired 
consciousness
Vancomycine Recovered This study
aCSF shunt, cerebrospinal fluid shunt included VPS or EVD.
bFrom shunt placement to infection onset.
cAdministered intravenously.
dND = not described.
eAdministered intrathecally.Page 2 of 5
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follow-up visit.
Patient 2
A 2-month-old male was admitted to the Pediatric Neuro-
surgery Unit for rapid head growth with a tense anterior
fontanel. He was placed in the same room where Patient
1 was still being cared for. Triventricular hydrocephalus
was evident on cranial ultrasonography, and MRI with
angiographic sequences disclosed a malformation involv-
ing Galen's vein that caused arteriovenous shunting and
obstruction of CSF flow through the aqueduct. The mal-
formation was treated successfully with intravascular
embolization, but 1 week later, the infant developed sei-
zures. Cerebral angiography confirmed occlusion of the
aneurysmal malformation, but computed tomography
revealed an intraventricular/subarachnoid hemorrhage.
An EVD was placed for continuous intracranial pressure
monitoring and collection of CSF specimens. All CSF cul-
tures were negative, including the one obtained during
EVD placement. Three days later, the child was febrile
(39.2°C) and drowsy. A cloudy CSF specimen collected
from the EVD contained 129 mg/dl protein, 20 mg/dl glu-
cose (blood glucose: 113 mg/dl), 800 leukocytes/mm3
(60% were polymorphonuclear cells), and 5 to 10 Gram-
positive cocci per microscopic field that were identified in
biochemical and molecular assays as S. lugdunensis.
The clinical picture was compatible with ventriculitis [9],
and IT vancomycin (40 mg/dose/day) was started imme-
diately after EVD replacement and continued for 14 days.
Cultures of the CSF and the tip of the original EVD grew
methicillin-resistant S. lugdunensis. Three blood cultures
were negative. Skin cultures (inguinal folds, surgical inci-
sion site) were all negative for S. lugdunensis. The infant's
condition rapidly improved after vancomycin was started,
and cultures of CSF collected 15 days later and of the sec-
ond EVD showed no growth. The infant was discharged
after 40 days of hospitalization. Six months later, he was
well with no evidence of infection and no acute neurolog-
ical signs.
Microbiological diagnosis
Our routine protocol for suspected CSF shunt infections
includes Gram staining of cytocentrifuged CSF, aerobic
culture at 35°C on MacConkey agar, microaerobic culture
(35°C in room air with 5% CO2) on Columbia and choc-
olate agars, anaerobic culture (35°C) on Schaedler agar
(all from bioMérieux, Marcy-L'Etoile, France), and 72
hours of aerobic and anaerobic cultures on brain-heart
infusion broth supplemented with 5% NaCl.
In these two patients, cultures of CSF and EVD tips on
Columbia agar produced yellowish beta-hemolytic colo-
nies (diameter: 0.8–2.5 mm) of Gram-positive cocci. Tube
coagulase tests with rabbit plasma (Becton Dickinson
Microbiology Systems, Sparks, MD) were negative. The
isolates were positive for catalase, clumping factor, pyrro-
lidonyl arylamidase, and ornithine decarboxylase. They
were identified as S. lugdunensis by the API ID32 STAPH
(bioMérieux) and the VITEK 2 (bioMérieux, Inc, Hazel-
wood, MO) systems.
Bacterial DNA was extracted from CSF specimens and cul-
ture isolates with the QIAmp DNA Mini kit (QIAGEN,
Hilden, Germany). Species-level identification was con-
firmed by sequencing of the 16S rRNA gene (using the
RIDOM entries) and the RNA polymerase B gene [10].
Sequence analysis of the 16S rRNA gene revealed 100%
homology with the prototype strain sequence of S. lugdun-
ensis ATCC 43809 (Z26899). A partial sequence of the
rpoB gene of each isolate revealed 99.5% homology with
the prototype strain sequence of S. lugdunensis ATCC
43809 (EF173667).
Antimicrobial susceptibility testing with the E-test (AB
Biodisk, Solna, Sweden) yielded the following MICs (μg/
ml): oxacillin, 256; vancomycin, 0.5; erythromycin, 0.03;
ciprofloxacin, 0.03; clindamycin, 0.03; rifampicin, 4.0;
quinupristin-dalfopristin, 0.5; linezolid, 1.0. Resistance
was defined by Clinical Laboratory Standards Institute
breakpoints [11]. The mecA gene (reflecting methicillin
resistance) was detected by PCR, as described by Geha and
colleagues [12]. Pulsed-field gel electrophoresis (PFGE)
analysis of SmaI- and ApaI-digested chromosomal DNA
[13] revealed identical profiles for all isolates recovered
from Patients 1 and 2 (data not shown).
Discussion
To date, there have been no reports of S. lugdunensis ven-
triculitis associated with EVDs, which are widely used in
neurosurgery for continuous intracranial pressure moni-
toring, injection of therapeutic agents, and temporary
external drainage of CSF [9]. EVD-associated CSF infec-
tions can be classified as ventriculostomy-related infec-
tions or ventriculitis [9]. The former are generally
associated with few clinical symptoms. The CSF is charac-
terized by culture- or Gram-stain-positivity with progres-
sive decrease in glucose and progressive increase in
proteins. Progression to ventriculitis is heralded by high-
grade fever and signs of meningitis (for example, nuchal
rigidity, photophobia, deteriorating mental status, sei-
zures, moribund appearance). The latter pattern was seen
in both of our patients. Fever and meningeal signs were
also reported in cases #2, 3 and 4 (Table 1), whereas the
VPS infection in case #1 was associated with severe non-
neurological symptoms (intra-abdominal sepsis with
purulent peritonitis) [7].Page 3 of 5
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leagues [6] had hospital-acquired infections, which devel-
oped 3 to 7 days after shunt insertion. The other infections
shown in Table 1 were evident at hospital admission and
would thus seem to be community-acquired (although in
one case [7] the admission occurred 14 days after a previ-
ous hospitalization during which a CSF shunt had been
inserted).
EVD use in critically ill neurosurgical patients is on the
rise and reported rates of infection associated with these
devices vary widely (from 0 to 45%). The prevailing opin-
ion is that the infecting agent is usually introduced during
EVD placement [9], which is consistent with the fact that
most EVD-associated infections are caused by skin flora,
particularly Staphylococcus epidermidis.
Like other CoNS species, S. lugdunensis is considered part
of the resident flora of the human skin and mucous mem-
branes, although the preferred carriage site seems to be the
perineum [14]. In both of our patients, infection onset
occurred a few days after surgery, the patients were being
cared for in the same hospital room, and all isolates dis-
played the same pulsotype. These findings are suggestive
of a common source, which unfortunately has not been
identified.
We cannot exclude the possibility that the infections were
transmitted during manipulation of the catheters. Health-
care-provider hand cultures (data not shown) and patient
skin cultures yielded no growth of S. lugdunensis. How-
ever, the staff surveillance cultures were collected after the
second child had been infected, not during the time of
EVD insertion, so the infection reservoir might have been
missed. Environmental cultures and inguinal cultures of
providers were not performed.
Hellbacher and colleagues [13] recently suggested that
PFGE is unsuitable for analyzing outbreak situations
involving S. lugdunensis. The homogeneity they observed
among 39 isolates collected over 4 years suggests that S.
lugdunensis is either a highly conserved species or that spe-
cific clones are more likely to cause invasive infections.
Other investigators [14], however, have found that PFGE
with SmaI macrorestriction analysis is inappropriate for
epidemiological investigations of S. lugdunensis infections
only when the strains are β-lactamase-producers, since
these isolates usually display a high level of genetic homo-
geneity. Identification of adequate typing tools for this
bacterial population will probably require multimodal
molecular characterization of a larger collection of S. lug-
dunensis strains.
The standard approach to CSF shunt infections caused by
a methicillin-resistant Staphylococcus spp. includes shunt
removal and intravenous vancomycin [9]. The previously
reported CSF infections caused by S. lugdunensis were
treated with intravenous vancomycin and/or oxacillin,
alone or with rifampicin, and bacteriological and clinical
cures were documented in all four [6-8]. CSF shunt infec-
tions caused by methicillin-resistant staphylococci are
common in our hospital, so when Gram-stain data indi-
cated the possibility of staphylococcal ventriculitis, our
patients were both treated empirically with vancomycin.
Later, the isolates' methicillin resistance was confirmed by
susceptibility testing and PCR analysis. Our patients were
treated with intrathecal vancomycin (40 mg/day), and
bacteriological and clinical cures were achieved in both
cases. Since then, guidelines have been published in
which considerably lower doses are recommended for
children (for example < 5 mg/24 hours) [15]. Although
no adverse effects were experienced by our patients, we
have modified our protocol, and staphylococcal CSF
shunt infections are now treated with IT vancomycin at
the dosage indicated above and with drug levels closely
monitored.
The frequency of S. lugdunensis infections may well be
underestimated. The species is likely to escape detection
by screening tests or certain automated microbiological
systems. Its ability to produce colony variations is well
known, described in three of the 11 strains included in the
initial description of S. lugdunensis in 1988 [1]. Awareness
of this risk has led to the development of genetic tools for
identifying this species [7]. No colony variation was
observed in either of our patients and all isolates consist-
ently exhibited the normal S. lugdunensis phenotype in
blood agar cultures.
Conclusion
Our experience confirms that, unlike other CoNS which
usually display low virulence, S. lugdunensis can cause
severe CNS infections in patients with implanted CSF
drainage devices. Accurate species-level identification of
isolates causing staphylococcal CSF shunt infections is
clearly essential for their successful treatment, but it is also
fundamental for epidemiological surveillance and for
improving our understanding of the pathophysiological
factors affecting the clinical outcome of these infections.
With the increasing use of invasive medical devices for
management of neurosurgical patients, CSF shunt infec-
tions are likely to become more common. Failure to iden-
tify their causative agents can be particularly disastrous
when the infection is due to S. lugdunensis.
Nucleotide sequence accession numbers
The sequences of the isolates evaluated in this study have
been deposited in the GenBank database under accession
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